portant marker for screening for hereditary nonpolyposis colorectal cancer (Lynch syndrome) as well as a prognos-tic and predictive marker for sporadic colorectal cancer (CRC). The mononucleotide microsatellite marker panel is a well-established and superior alternative to the tradi-tional Bethesda MSI analysis panel, and does not require testing for corresponding normal DNA. The most com-mon MSI detection techniques—fluorescent capillary electrophoresis and denaturing HPLC (DHPLC)—both have advantages and drawbacks. A new high-resolution melting (HRM) analysis method enables rapid identifica-tion of heteroduplexes in amplicons by their lower ther-mal stability, a technique that overcomes the main short-comings of capillary electrophoresis ...
Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary non-polypo...
Hereditary Nonpolyposis Colorectal Cancer (HNPCC), an autosomal dominant susceptibility syndroriie, ...
IF 5.65International audienceBackground Every colorectal cancer (CRC) patient should be tested for m...
portant marker for screening for hereditary nonpolyposis colorectal cancer (Lynch syndrome) as well ...
A significant proportion (∼15%) of colorectal cancer (CRC), either sporadic or arising in the settin...
International audienceMicrosatellite instability (MSI)1 is characterized by the accumulation of muta...
International audienceEvery colorectal cancer (CRC) patient should be tested for microsatellite inst...
Colorectal cancer with microsatellite instability (MSI) may occur sporadically or be inherited in ca...
Abstract Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary n...
Hereditary Nonpolyposis Colorectal Cancer (I-INPCC) is an autosomal dominant syndrome characterized ...
Microsatellite instability (MSI) is a hallmark of the DNA replication error phenotype, due to the in...
Microsatellite instability (MSI) is used to screen colorectal cancers (CRC) for Lynch Syndrome, and ...
Detection of microsatellite instability (MSI) is the standard part of mutational analysis in heredit...
Abstract Background Analysis of high microsatellite instability (MSI-H) phenotype in colorectal carc...
Hereditary Nonpolyposis Colorectal Cancer (HNPCC), an autosomal dominant susceptibility syndroriie, ...
Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary non-polypo...
Hereditary Nonpolyposis Colorectal Cancer (HNPCC), an autosomal dominant susceptibility syndroriie, ...
IF 5.65International audienceBackground Every colorectal cancer (CRC) patient should be tested for m...
portant marker for screening for hereditary nonpolyposis colorectal cancer (Lynch syndrome) as well ...
A significant proportion (∼15%) of colorectal cancer (CRC), either sporadic or arising in the settin...
International audienceMicrosatellite instability (MSI)1 is characterized by the accumulation of muta...
International audienceEvery colorectal cancer (CRC) patient should be tested for microsatellite inst...
Colorectal cancer with microsatellite instability (MSI) may occur sporadically or be inherited in ca...
Abstract Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary n...
Hereditary Nonpolyposis Colorectal Cancer (I-INPCC) is an autosomal dominant syndrome characterized ...
Microsatellite instability (MSI) is a hallmark of the DNA replication error phenotype, due to the in...
Microsatellite instability (MSI) is used to screen colorectal cancers (CRC) for Lynch Syndrome, and ...
Detection of microsatellite instability (MSI) is the standard part of mutational analysis in heredit...
Abstract Background Analysis of high microsatellite instability (MSI-H) phenotype in colorectal carc...
Hereditary Nonpolyposis Colorectal Cancer (HNPCC), an autosomal dominant susceptibility syndroriie, ...
Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary non-polypo...
Hereditary Nonpolyposis Colorectal Cancer (HNPCC), an autosomal dominant susceptibility syndroriie, ...
IF 5.65International audienceBackground Every colorectal cancer (CRC) patient should be tested for m...